New french questionnaires aim to better diagnose dizziness and detachment disorders

NCT ID NCT05249283

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested French versions of two questionnaires: one measures feelings of detachment from oneself (depersonalization), and the other helps diagnose a chronic dizziness condition called PPPD. Researchers enrolled 612 adults with and without balance disorders to ensure the translations are accurate and reliable. The goal is to improve diagnosis and understanding of these conditions, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

612 people

The number who actually took part.

Started

Mar 2022

Finished

Oct 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: For patient: * Age ≥ 18 years * Patient with acute or chronic otoneurological disorders * Patient having or having experienced dizziness and / or balance disorders * Patient with PPPD * Fluency in French * Having given free and informed written consent * Being affiliated with or benefiting from social security For control subjects: * Age ≥ 18 years * Fluency in French * Having given free and informed written consent * Being affiliated with or benefiting from social security. Exclusion Criteria: For patient: -Past or present psychiatric and neurological disease (other than otoneurological or PPPD, as declared by the participant) For control subjects: -Past or present psychiatric and neurological disease (as declared by the participant) and vestibular and/or auditory system disorders (as declared by the participant) For all participants: * Persons still in a period of exclusion from another study and persons simultaneously participating in another study * Subject to a measure for the protection of justice

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Patients presenting or having experienced dizziness and / or balance disorders are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpital Européen Marseille

    Marseille, France